Company page

Aktis Oncology, Inc.

Aktis Oncology, Inc. is a public company listed under the ticker AKTS, operating in the American market. The company has a market capitalization of approximately $1.15 billion. Aktis Oncology focuses on developing innovative cancer therapies aimed at improving patient outcomes.

profileAKTSAI content: aiUpdated May 29, 2026/company/aktis-oncology-inc-common-stock
Aktis Oncology, Inc. logo
Ticker
AKTS
Market cap
$1.15B
Sector
Health Technology
Industry
Pharmaceuticals: Major